Learn more

MAX DELBRÜCK CT FÜR MOLEKULARE MEDIZIN

Overview
  • Total Patents
    14
  • GoodIP Patent Rank
    182,961
About

MAX DELBRÜCK CT FÜR MOLEKULARE MEDIZIN has a total of 14 patent applications. Its first patent ever was published in 2007. It filed its patents most often in EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and organic fine chemistry are MAX DELBRUCK CENTRUM FUR MOLEKULARE MEDIZIN IN DER HELMHOLTZ GEMEINSCHAFT, TRIMERIS INC and MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFT.

Patent filings in countries

World map showing MAX DELBRÜCK CT FÜR MOLEKULARE MEDIZINs patent filings in countries

Patent filings per year

Chart showing MAX DELBRÜCK CT FÜR MOLEKULARE MEDIZINs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Oden Felix 3
#2 Marino Stephen 3
#3 Daumke Oliver 3
#4 Landthaler Markus 2
#5 Höpken Uta 2
#6 Müller Gerd 2
#7 Pezzutto Antonio 2
#8 Olal Daniel 2
#9 Lipp Martin 2
#10 Schmetzer Oliver 2

Latest patents

Publication Filing date Title
WO2016005589A2 Novel gene panel for the diagnosis of dilated cardiomyopathy
EP3067366A1 Combined T cell receptor gene therapy of cancer against MHC I and MHC II-restricted epitopes of the tumor antigen NY-ESO-1
EP3061761A1 Xanthine derivatives, their use as a medicament, and pharmaceutical preparations comprising the same
EP2914628A1 An antibody that binds cd269 (bcma) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseases
WO2014044793A2 Cd22-binding peptides
EP2568995A1 Therapeutic use of agonists of bradykinin receptor 1 or 2, for modulation collateral blood vessel growth